Associations of Socioeconomic Status, Parental Smoking and Parental E-Cigarette Use with 10-11-Year-Old Children's Perceptions of Tobacco Cigarettes and E-Cigarettes: Cross Sectional Analysis of the CHETS Wales 3 Survey.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
21 01 2020
Historique:
received: 27 09 2019
revised: 07 01 2020
accepted: 09 01 2020
entrez: 25 1 2020
pubmed: 25 1 2020
medline: 18 9 2020
Statut: epublish

Résumé

This study examines primary schoolchildren's perceptions of e-cigarettes and tobacco cigarettes, and associations with parental smoking, vaping and socioeconomic status. Survey of 2218 10-11-year-old children in 73 schools in Wales. Overall, 36% reported that a parent figure smoked compared to 21% for vaping, with parental smoking lower in affluent families (OR = 0.72; 95% CI = 0.68 to 0.76). Overall, 1% had tried a cigarette, while 5% had tried an e-cigarette. Most said they would not smoke or vape in 2 years' time; susceptibility to vaping (20%) was higher than smoking (12%). Exposure to and perceptions of tobacco cigarettes were more positive for children of smokers. Having a parent who vaped was associated with exposure to and positive perceptions of e-cigarettes, but not smoking. Most children perceived e-cigarettes as used by adults to stop smoking (64%). Susceptibility to smoking (OR = 0.57; 95% CI = 0.41 to 0.79) and vaping (OR = 0.78; 95% CI = 0.62 to 0.99) were lower among children who perceived e-cigarettes as cessation aids. Parental smoking continues to be concentrated in poorer families. This study provides no evidence that parental vaping in the absence of smoking is associated with more positive perceptions of tobacco cigarettes. Communicating to children the role of e-cigarettes as cessation devices for smokers may help to limit their appeal to young people.

Sections du résumé

BACKGROUND
This study examines primary schoolchildren's perceptions of e-cigarettes and tobacco cigarettes, and associations with parental smoking, vaping and socioeconomic status.
METHODS
Survey of 2218 10-11-year-old children in 73 schools in Wales.
RESULTS
Overall, 36% reported that a parent figure smoked compared to 21% for vaping, with parental smoking lower in affluent families (OR = 0.72; 95% CI = 0.68 to 0.76). Overall, 1% had tried a cigarette, while 5% had tried an e-cigarette. Most said they would not smoke or vape in 2 years' time; susceptibility to vaping (20%) was higher than smoking (12%). Exposure to and perceptions of tobacco cigarettes were more positive for children of smokers. Having a parent who vaped was associated with exposure to and positive perceptions of e-cigarettes, but not smoking. Most children perceived e-cigarettes as used by adults to stop smoking (64%). Susceptibility to smoking (OR = 0.57; 95% CI = 0.41 to 0.79) and vaping (OR = 0.78; 95% CI = 0.62 to 0.99) were lower among children who perceived e-cigarettes as cessation aids.
CONCLUSIONS
Parental smoking continues to be concentrated in poorer families. This study provides no evidence that parental vaping in the absence of smoking is associated with more positive perceptions of tobacco cigarettes. Communicating to children the role of e-cigarettes as cessation devices for smokers may help to limit their appeal to young people.

Identifiants

pubmed: 31973060
pii: ijerph17030683
doi: 10.3390/ijerph17030683
pmc: PMC7038099
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12017/13
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C57590/A25754
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU13
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023233/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Tob Control. 2019 Jan;28(1):110-112
pubmed: 29654121
Thorax. 2011 Oct;66(10):847-55
pubmed: 21325144
Eur Respir J. 2015 Sep;46(3):697-706
pubmed: 26022951
Harm Reduct J. 2013 Nov 18;10:30
pubmed: 24238406
Pediatrics. 2018 Jan;141(Suppl 1):S40-S50
pubmed: 29292305
Tob Control. 2016 Mar;25(2):147-52
pubmed: 25535293
Nicotine Tob Res. 2019 Sep 19;21(10):1320-1330
pubmed: 29788314
BMJ. 2019 Jun 20;365:l2219
pubmed: 31221636
Addiction. 2020 Apr;115(4):782-783
pubmed: 31785207
Scand J Public Health. 2019 Apr 11;:1403494819839854
pubmed: 30973093
Lancet. 2013 Nov 16;382(9905):1629-37
pubmed: 24029165
J Adolesc Health. 2018 May;62(5):539-547
pubmed: 29499983
Nicotine Tob Res. 2019 Apr 17;21(5):695-698
pubmed: 29660054
Tob Control. 2017 Aug 17;:
pubmed: 28818839
Lancet. 2019 Oct 12;394(10206):1297
pubmed: 31609211
BMJ Open. 2015 Apr 15;5(4):e007072
pubmed: 25877272
BMJ Open. 2017 Feb 3;7(2):e012784
pubmed: 28159848
Int J Environ Res Public Health. 2018 Jun 06;15(6):
pubmed: 29882828
BMC Public Health. 2019 Nov 6;19(1):1469
pubmed: 31694602
Tob Control. 2017 Jan;26(1):98-104
pubmed: 27220621
Addiction. 2016 Jun;111(6):1118-9
pubmed: 26920514
Tob Control. 2018 May 28;:
pubmed: 29807947
Tob Control. 2017 May;26(3):260-268
pubmed: 27122064
Tob Control. 2017 Dec;26(e2):e85-e91
pubmed: 28003324
Br J Gen Pract. 2019 Jan;69(678):e8-e14
pubmed: 30397013
Lancet. 2019 Nov 16;394(10211):1804-1805
pubmed: 31635884
Tob Control. 2020 Mar;29(2):207-216
pubmed: 30936390
Int J Drug Policy. 2017 Nov;49:58-64
pubmed: 28987929
BMJ Open. 2015 Jan 30;5(1):e006914
pubmed: 25636793
Tob Control. 2019 Nov;28(6):629-635
pubmed: 30459182
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Evaluation (Lond). 2019 Jan;25(1):23-45
pubmed: 30705608
Child Indic Res. 2016;9:771-784
pubmed: 27489572
J Am Coll Cardiol. 2019 Dec 24;74(25):3112-3120
pubmed: 31740017
Am J Public Health. 2015 Oct;105(10):1967-72
pubmed: 26270285
Addiction. 2019 Oct 16;:
pubmed: 31621131
NPJ Prim Care Respir Med. 2016 Nov 17;26:16067
pubmed: 27853176
Lancet. 2019 Dec 7;394(10214):2041-2043
pubmed: 31711628
SAGE Open Med. 2019 Aug 18;7:2050312119871405
pubmed: 31452888
Int J Drug Policy. 2020 Jan;75:102598
pubmed: 31785547
BMJ. 2019 Sep 10;366:l5445
pubmed: 31506254
Soc Sci Med. 2019 Oct;238:112498
pubmed: 31446371

Auteurs

Graham F Moore (GF)

DECIPHer, School of Social Sciences, Cardiff University, Wales CF10 3BD, UK.
SPECTRUM Consortium, London SW20 0AB, UK.

Lianna Angel (L)

DECIPHer, School of Social Sciences, Cardiff University, Wales CF10 3BD, UK.

Linsay Gray (L)

MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Scotland G2 3AX, UK.

Lauren Copeland (L)

DECIPHer, School of Social Sciences, Cardiff University, Wales CF10 3BD, UK.

Jordan Van Godwin (J)

DECIPHer, School of Social Sciences, Cardiff University, Wales CF10 3BD, UK.

Jeremy Segrott (J)

DECIPHer, Centre for Trials Research, Cardiff University, Wales CF14 4YS, UK.

Britt Hallingberg (B)

Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Wales CF5 2YB, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH